These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26587148)

  • 41. Clinical study of cutaneous drug eruptions in 200 patients.
    Raksha MP; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(1):80. PubMed ID: 18193504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Sanclemente G; De la Roche CA; Escobar CE; Falabella R
    Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
    [No Abstract]   [Full Text] [Related]  

  • 44. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
    Giglio P
    South Med J; 2003 Mar; 96(3):320-1. PubMed ID: 12659372
    [No Abstract]   [Full Text] [Related]  

  • 45. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Valeyrie-Allanore L; Wolkenstein P; Brochard L; Ortonne N; Maître B; Revuz J; Bagot M; Roujeau JC
    Br J Dermatol; 2010 Oct; 163(4):847-53. PubMed ID: 20500799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dermatologic emergencies.
    Usatine RP; Sandy N
    Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of macrophage migration inhibition factor in toxic epidermal necrolysis.
    Halevy S; Livni E
    Int J Dermatol; 1997 Oct; 36(10):776-8. PubMed ID: 9372356
    [No Abstract]   [Full Text] [Related]  

  • 50. Thalidomide in toxic epidermal necrolysis.
    Klausner JD; Kaplan G; Haslett PA
    Lancet; 1999 Jan; 353(9149):324. PubMed ID: 9929047
    [No Abstract]   [Full Text] [Related]  

  • 51. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period.
    Kauppinen K; Stubb S
    Acta Derm Venereol; 1984; 64(4):320-4. PubMed ID: 6209890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report.
    Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM
    Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-reactivity in AED-Induced Severe Cutaneous Adverse Reaction: A Case Report.
    Khor AH; Lim KS; Tan CT; Kwan Z; Ng CC
    J Investig Allergol Clin Immunol; 2016; 26(5):329-331. PubMed ID: 27763865
    [No Abstract]   [Full Text] [Related]  

  • 55. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.
    Nassif A; Bensussan A; Dorothée G; Mami-Chouaib F; Bachot N; Bagot M; Boumsell L; Roujeau JC
    J Invest Dermatol; 2002 Apr; 118(4):728-33. PubMed ID: 11918724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous adverse drug reactions: an 8-year retrospective study on hospitalized patients in Southern China.
    Wang F; Li Y; Mo Y; Shen C; Yang L; Zhang X
    Indian J Dermatol Venereol Leprol; 2012; 78(4):488-90. PubMed ID: 22772622
    [No Abstract]   [Full Text] [Related]  

  • 58. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU; Njinaka I; Ehimiyen ET
    Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T; Uchi H; Moroi Y; Furue M
    Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.